Good company and team, unclear intentions - Mitarbeiter (anonym) bei Standard BioTools: Mitarbeiterbewertung

4.0
9. Dez. 2022
Mitarbeiter (anonym)
Empfehlen
CEO-Befürwortung
Geschäftsprognose

Pros

Really incredible technology (CTI) - revamped the face of Cytometry precision and reliability Intelligent and vibrant team Disruptive technology - won't get boring

Kontras

Targets and business model are precarious. Still hopeful. Despite a passionate and supportive manager in EMEA, distance and changing landscape contributes to lack of cohesion and can isolate colleagues Worried about long term goal

Mehr Bewertungen zu Standard BioTools entdecken

5.0
2. Apr. 2025
Mitarbeiter (anonym)
Empfehlen
CEO-Befürwortung
Geschäftsprognose

Pros

Hard working employees and managers that go to bat for their employees

Kontras

Lack of help in marketing

1.0
12. Apr. 2026
Empfehlen
CEO-Befürwortung
Geschäftsprognose

Pros

Unique Technology & Recently updated. Very good for specific applications and research. Respectable pay and benefits if you don't get RIF'd after your first few months on the job. Technology is as unique as a 3 dollar bill.

Kontras

Company reduces workforce about every year & is owned by private equity (i.e. - Very unstable/based only on quarterly profits & not individual contributions). High Turnover so DO NOT expect a long career here. Solutions are not valuable to a majority of institutions. The majority of the target market has abandoned the technology due to poor prior experiences and will not reconsider it.

1
Bewertungen anzeigen nach: Hilfreich|Sterne|Datum|Alle